Drug Substance

Our aim is to enable bio-manufacturers to collaborate on their most challenging operational strategies; those that can’t be achieved in isolation, but require a critical mass of users to define common requirements for suppliers or to align on interpretations of regulatory requirements.

Drug Substance

 

Biopharma manufacturers achieve their goals by collaborating with each other, their supplier partners and health agencies to define manufacturer requirements and best practices which are then used to implement modern biopharma supply chains.

The program is developed and owned by the governing body of biopharma manufacturers. This ensures that the topics worked on are of the highest importance to operational leaders and aligned to their own corporate goals.

Biopharma manufacturers achieve their goals by collaborating with each other, their supplier partners and health agencies to define manufacturer requirements and best practices which are then used to implement modern biopharma supply chains.

The program is developed and owned by the governing body of biopharma manufacturers. This ensures that the topics worked on are of the highest importance to operational leaders and aligned to their own corporate goals.

Download “Drug Substance 2018 Deliverables” BioPhorum-DS-Delivered-Outputs-2018-Rev-2-5.pdf – 363 KB


 

Subscribe to our mailing list

Please select all the ways you would like to hear from BioPhorum:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.